New Blood-Thinner strategy aims to cut bleeding after heart device implants
NCT ID NCT07616414
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a stepwise blood-thinning approach to the standard method in 424 patients with atrial fibrillation who are at high risk for stroke and need a heart device like a pacemaker. The stepwise plan involves stopping the blood thinner one day before surgery and restarting with a lower dose for a week afterward. The goal is to see if this reduces pocket hematoma (bleeding under the skin) within 30 days after surgery, while still preventing blood clots.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- edoxaban or rivaroxaban (blood thinners)
- What this could lead to
- If successful, this could offer a safer way to manage blood thinners around heart device surgery, reducing bleeding complications while still preventing strokes.
- What could go wrong
- This is an early-stage trial with only 424 participants, so results may not apply to all patients. The stepwise approach might not lower bleeding risk as expected or could increase stroke risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC IMPLANTABLE ELECTRONIC DEVICE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital
Beijing, Beijing Municipality, 100037, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new device suck out deadly lung clots?
- Could a pill replace an IV to cut bleeding in heart surgery?
- Do surgeons follow the rules for bleeding control? new study investigates
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19
- Blood thinner levels under microscope to prevent clots and bleeding
- New blood test may predict bleeding risk after heart surgery